Search
Cardiol Therapeutics Inc
CRDLAdd to Watchlist
1.050USD
0.0000.00%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
117.47MMarket Cap
LossP/E TTM
More Details of Cardiol Therapeutics Inc Company
Cardiol Therapeutics Inc. is a Canada-based clinical-stage life sciences company focused on developing anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. The Company's lead small-molecule drug candidate, CardiolRx (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease. It holds investigational new drug application authorization from the United States Food and Drug Administration (US FDA) to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart: recurrent pericarditis and acute myocarditis. The MAVERIC Program in recurrent pericarditis, an inflammatory disease, comprises the completed Phase II MAvERIC-Pilot study (NCT05494788) and the ongoing Phase III MAVERIC trial (NCT06708299). The Company is also developing CRD-38, a novel subcutaneously administered drug formulation intended for use in heart failure.
Cardiol Therapeutics Inc Info
Ticker SymbolCRDL
Company nameCardiol Therapeutics Inc
IPO dateDec 20, 2018
CEOElsley (David)
Number of employees18
Security typeOrdinary Share
Fiscal year-endDec 20
Address602-2265 Upper Middle Road East
CityOAKVILLE
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryCanada
Postal codeL6H 0G5
Phone12899100850
Websitehttps://www.cardiolrx.com/
Ticker SymbolCRDL
IPO dateDec 20, 2018
CEOElsley (David)
Company Executives of Cardiol Therapeutics Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Peter Pekos
Mr. Peter Pekos
Independent Director
Independent Director
506.04K
--
Mr. Colin George Stott
Mr. Colin George Stott
Independent Director
Independent Director
142.50K
--
Ms. Jennifer M. Chao
Ms. Jennifer M. Chao
Independent Director
Independent Director
133.33K
--
Ms. Teri Loxam
Ms. Teri Loxam
Independent Director
Independent Director
133.33K
--
Mr. Bernard Lim
Mr. Bernard Lim
Chief Operating Officer
Chief Operating Officer
40.00K
+25.00%
Mr. David Elsley
Mr. David Elsley
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Dr. Guillermo Torre-Amione, M.D., Ph.D.
Dr. Guillermo Torre-Amione, M.D., Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Christopher (Chris) Waddick, CPA
Mr. Christopher (Chris) Waddick, CPA
Chief Financial Officer, Corporate Secretary, Director
Chief Financial Officer, Corporate Secretary, Director
--
--
Mr. Trevor Burns
Mr. Trevor Burns
Investor Relations
Investor Relations
--
--
Dr. Andrew Hamer
Dr. Andrew Hamer
Chief Medical Officer, Head of Research and Development
Chief Medical Officer, Head of Research and Development
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Peter Pekos
Mr. Peter Pekos
Independent Director
Independent Director
506.04K
--
Mr. Colin George Stott
Mr. Colin George Stott
Independent Director
Independent Director
142.50K
--
Ms. Jennifer M. Chao
Ms. Jennifer M. Chao
Independent Director
Independent Director
133.33K
--
Ms. Teri Loxam
Ms. Teri Loxam
Independent Director
Independent Director
133.33K
--
Mr. Bernard Lim
Mr. Bernard Lim
Chief Operating Officer
Chief Operating Officer
40.00K
+25.00%
Mr. David Elsley
Mr. David Elsley
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
FAQs
Who are the top five shareholders of Cardiol Therapeutics Inc?
The top five shareholders of Cardiol Therapeutics Inc are: Mr. Peter Pekos
How many institutions hold shares of Cardiol Therapeutics Inc (CRDL)?
As of 2026Q1, 102 institutions hold shares of Cardiol Therapeutics Inc, with a combined market value of approximately 25.40M, accounting for 22.72% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 1731619.00.